This doesn't even scratch the surface for employer insurance. That shoe drops next year.
This is only the individual plans and market.
Read an article the other day- Wash Post- eye treatment- 2 k a shot or using a chemo drug, diluted at a specialty shop that does that - 50.00 a crack
The company refuses to produce the chemo drug as they state the new, 2 k per is different- all they did was add a molecule - no difference in the results.
The other thing is - Medicare pays the Dr 6 5 of the drig cost- then their are kickback from the company to the dr.
Guess what happens.
An effective eye drug is available for $50. But many doctors choose a $2,000 alternative. - The Washington Post
An effective eye drug is available for $50. But many doctors choose a $2,000 alternative.
The two drugs have been declared equivalently miraculous. Tested side by side in six major trials, both prevent blindness in a common old-age affliction. Biologically, they are cousins. They’re even made by the same company.
But one holds a clear price advantage.
Avastin costs about $50 per injection.
Lucentis costs about $2,000 per injection.
Doctors choose the more expensive drug more than half a million times every year, a choice that costs the Medicare program, the largest single customer,
an extra $1 billion or more annually.
Genentech, a division of the Roche Group, makes both products but reaps far more profit when it sells the more expensive drug. Although Lucentis is about 40 times as expensive as Avastin to buy, the cost of producing the two drugs is similar, according to scientists familiar with the drugs and the industry.
Doctors, meanwhile, may benefit when they choose the more expensive drug. Under Medicare repayment rules for drugs given by physicians, they are reimbursed for the average price of the drug plus 6 percent. That means a drug with a higher price may be easier to sell to doctors than a cheaper one. In addition, Genentech offers rebates to doctors who use large volumes of the more expensive drug.